Alfuzosin Hydrochloride

盐酸阿夫唑嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAlfuzosin Hydrochloride
Drug Alias NameAlfuzosinum阿夫唑秦盐酸阿呋唑嗪alfuzosineUroxatrol +[17] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsConstipationColicUrinary Retention +[10] 
Global Approved IndicationsProstatic Hyperplasia
Approved Indications in ChinaProstatic Hyperplasia
Original Approved Country/TerritoryN/A
Original Approved Date1988/01/01
Country/TerritoryBulgariaCanadaUnited States +[31] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCovis Pharma
China Registration ClassN/A

Develop Information

Active CompaniesPharma NuevaINTERNATIONAL BIO SERVICES CO LTDSanofi-Synthelabo Groupe +[4] 
Inactive CompaniesUniversity Of MinnesotaTorrent Pharmaceuticals LtdSanofi +[6] 
Active IndicationsProstatic Hyperplasia
Inactive IndicationsConstipationColicUrinary Retention +[9] 

Other Information

ATC CodeG04CA01
Related LinksWikipediaDrugBankKEGG